Furosemide
| Subclass of | furan, benzenesulfonamides, aromatic carboxylic acid, aniline, monochlorobenzene |
|---|---|
| Get use | Medication |
| Chemical formula | C₁₂H₁₁ClN₂O₅S |
| Canonical SMILES | C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl |
| Active ingredient in | Lasix |
| Physically dey interact plus | Solute carrier family 12 member 2, G protein-coupled receptor 35, Solute carrier family 12 member 1 |
| Legal status (medicine) | boxed warning |
| Pregnancy category | Australian pregnancy category C, US pregnancy category C |
| Manufacturer | Pfizer |
| Subject has role | sodium potassium chloride symporter inhibitors, diuretic, essential medicine |
| MCN code | 2935.90.21 |
Furosemide, dem sell under de brand name Lasix among odas, be a loop diuretic medication dem use to treat edema secof heart failure, liver scarring, anaa kidney disease.[1] Furosemide sanso fi be used for de treatment of high blood pressure.[1] Dem fi take am intravenously anaa orally.[1] When dem give intravenously, furosemide typically dey take effect within five minutes; wen dem take am orally, e typically dey metabolize within an hour.[1]
Common side effects dey include orthostatic hypotension (decrease insyd blood pressure while standing, den associated lightheadedness), tinnitus (ringing insyd de ears), den photosensitivity (sensitivity to light).[1] Potentially serious side effects dey include electrolyte abnormalities, low blood pressure, den hearing loss.[1] Dem dey recommend say serum electrolytes (especially potassium), serum CO2, creatinine, BUN levels, den liver den kidney functioning be monitored insyd patients wey dey take furosemide. E sanso e recommended to be alert for de occurrence of any potential blood dyscrasias.[1]
Furosemide dey work by decreasing de reabsorption of sodium by de kidneys.[1] Common side effects of furosemide injection dey include hypokalemia (low potassium level), hypotension (low blood pressure), den dizziness.[2]
Na dem patent furosemide insyd 1959 wey dem approve am for medical use insyd 1964.[3] E dey on de World Health Organization's List of Essential Medicines.[4] Insyd de United States, e be available as a generic medication.[1] Insyd 2023, na e be de 29th most commonly prescribed medication insyd de United States, plus more dan 19 million prescriptions.[5][6] Insyd 2020/21 na e be de twentieth most prescribed medication insyd England.[7] E dey on de World Anti-Doping Agency ein banned drug list secof concerns say e fi mask oda drugs.[8] E sanso be used insyd race horses for de treatment den prevention of exercise-induced pulmonary hemorrhage.[9][10]
References
[edit | edit source]- 1 2 3 4 5 6 7 8 9 "Furosemide". The American Society of Health-System Pharmacists. Archived from the original on 19 November 2015. Retrieved 23 October 2015.
- ↑ "Coronavirus (COVID-19) Update: December 22, 2020". U.S. Food and Drug Administration (Press release). 22 December 2020. Retrieved 22 December 2020.
- ↑ Fischer J, Ganellin CR (2006). Analogue-based Drug Discovery. John Wiley & Sons. p. 458. ISBN 978-3-527-60749-5.
- ↑ World Health Organization (2023). The selection and use of essential medicines 2023: web annex A: World Health Organization model list of essential medicines: 23rd list (2023). Geneva: World Health Organization. hdl:10665/371090. WHO/MHP/HPS/EML/2023.02.
- ↑ "Top 300 of 2023". ClinCalc. Archived from the original on 12 August 2025. Retrieved 12 August 2025.
- ↑ "Furosemide Drug Usage Statistics, United States, 2014 - 2023". ClinCalc. Retrieved 13 August 2025.
- ↑ "PCA England". NHS Business Services Authority. Retrieved 8 August 2022.
- ↑ "World Anti-doping Code International Standard Prohibited List 2022" (PDF). 2022. p. 12. Archived (PDF) from the original on 10 July 2022. Retrieved 27 July 2022.
- ↑ Sullivan S, Hinchcliff K (April 2015). "Update on exercise-induced pulmonary hemorrhage". The Veterinary Clinics of North America. Equine Practice. 31 (1): 187–198. doi:10.1016/j.cveq.2014.11.011. PMID 25770069.
- ↑ Hinchcliff KW, Couetil LL, Knight PK, Morley PS, Robinson NE, Sweeney CR, van Erck E (2015). "Exercise induced pulmonary hemorrhage in horses: American College of Veterinary Internal Medicine consensus statement". Journal of Veterinary Internal Medicine. 29 (3): 743–758. doi:10.1111/jvim.12593. PMC 4895427. PMID 25996660.
Read further
[edit | edit source]- Aventis Pharma (1998). Lasix Approved Product Information. Lane Cove: Aventis Pharma Pty Ltd.
- Forney B (2007). Understanding Equine Medications, Revised Edition (Horse Health Care Library). Eclipse Press. ISBN 978-1-58150-151-3.
External links
[edit | edit source]- "Furosemide Injection". MedlinePlus.
- Lasix and horse bleeding
- CS1:Vancouver names with accept markup
- Commons category link from Wikidata
- Anthranilic acids
- Carbonic anhydrase inhibitors
- Chemical substances for emergency medicine
- Chloroarenes
- Equine medications
- 2-Furyl compounds
- GABAA receptor negative allosteric modulators
- Glycine receptor antagonists
- Loop diuretics
- Nephrotoxins
- NMDA receptor antagonists
- Sanofi
- Sulfonamides
- World Anti-Doping Agency prohibited substances
- World Health Organization essential medicines
- Translated from MDWiki